ARTICLE

FindCenter AddIcon

Ketamine Is Revealing a New Understanding of Depression and the Brain

By Lauren Tanabe

Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.

Read on elemental.medium.com

FindCenter Post-Image

Psychedelic Medicine: The Healing Powers of LSD, MDMA, Psilocybin, and Ayahuasca

Explores the potential of psychedelics as medicine and the intersections of politics, science, and psychedelics • Explores the tumultuous history of psychedelic research, the efforts to restore psychedelic therapies, and the links between psychiatric drugs and mental illness • Offers...

Book
Richard Louis Miller
2017
FindCenter AddIcon
FindCenter Post-Image

How to Change Your Mind: What the New Science of Psychedelics Teaches Us about Consciousness, Dying, Addiction, Depression, and Transcendence

When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...

Book
Michael Pollan
2019
FindCenter AddIcon
FindCenter Post-Image

LSD: Doorway to the Numinous: The Groundbreaking Psychedelic Research into Realms of the Human Unconscious

A pioneering book that explores the unknown landscape of human consciousness induced by LSD and other psychedelics • Shows the relationship between shamanism, near death experiences, and other mystical and altered states with those induced by psychedelics • Lays the conceptual foundation for...

Book
Stanislav Grof
2009
FindCenter AddIcon
FindCenter Post-Image
01:51

The Importance of the Psychedelic Experience During Ketamine Infusions

Part of the way healing occurs during the ketamine infusion is due to the non-ordinary (psychedelic) experience. In this non-ordinary state, the unconscious mind is accessed and allows processing of unresolved emotions and traumatic events.

Video
2020
FindCenter AddIcon
FindCenter Post-Image

Listening to Ayahuasca: New Hope for Depression, Addiction, PTSD, and Anxiety

Used for thousands of years by indigenous tribes of the Amazon rain forest, the mystical brew ayahuasca is now becoming increasingly popular in the West.

Book
Rachel Harris
2017
FindCenter AddIcon
FindCenter Post-Image
01:03:04

Christopher Timmermann—the Neurophenomenology of the DMT State

The Neurophenomenology of the DMT State, presented by Christopher Timmermann from Imperial College London, UK

Video
2019
FindCenter AddIcon
FindCenter Post-Image
01:24:39

Revealing the Mind: The Promise of Psychedelics

Nearly every culture throughout history has used chemicals that alter consciousness for spiritual exploration. In the 20th century these drugs caught the attention of scientists. Psychedelics, as they were named, proved effective at treating intractable illnesses like depression and addiction.

Video
Michael Pollan
2019
FindCenter AddIcon
FindCenter Post-Image
56:33

Hofmann’s Potion—Albert Hofmann LSD Documentary

By the mid-1950s, LSD research was being published in medical and academic journals all over the world. It showed potential benefits in the treatment of alcoholism, drug addiction, and other mental illnesses. This film explores those potential benefits, and the researchers who explored them.

Video
Albert Hofmann
2012
FindCenter AddIcon
FindCenter Post-Image
01:01:21

Psychedelics: Treating Addiction, Depression and Anxiety with Dr. Roland Griffiths

Psychedelics were the subject of serious medical research in the 1940s to the 1960s, when many scientists believed some of the mind-bending compounds held tremendous therapeutic promise for treating a number of conditions including severe mental health problems and alcohol addiction.

Video
Roland Griffiths
2019
FindCenter AddIcon
FindCenter Post-Image
01:15:24

Roland Griffiths, Ph.D. on Psilocybin, Psychedelic Therapies & Mystical Experiences

Dr. Roland R. Griffiths is a clinical pharmacologist at Johns Hopkins. Dr. Griffiths has been researching mood-altering compounds for over 40 years, has published over 360 times, and started the psilocybin research program at Johns Hopkins nearly 2 decades ago.

Video
Roland Griffiths
2017
FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression